Tezspire®

Understanding Tezspire®

Tezspire® is a first-in-class biologic used for the treatment of severe asthma. It works by blocking thymic stromal lymphopoietin (TSLP), a key inflammatory cytokine that drives multiple asthma pathways. By targeting and inhibiting TSLP, Tezspire® helps reduce airway inflammation, making it easier to breathe and improving asthma symptom control in patients with severe asthma.

How Tezspire® Works:

• Blocks TSLP, a key driver of airway inflammation
• Reduces inflammation, making breathing easier
• Helps control severe asthma symptoms, reducing flare-ups and attacks

FDA Approval:

• Tezspire®: Approved on December 17, 2021

For more information, please visit the Tezspire® patient website and speak with your healthcare provider to determine if Tezspire® is the right treatment option for you.